Analyst Ratings for Protalix BioTherapeutics (PLX)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 3.8 / 10
Percentile Rank: 36%
Rating Score: 3.8 / 10
Percentile Rank: 36%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/23/2015 | Jefferies » Updated 10/19/2017 |
N/A | Upgrade | Buy (N/A) |
2.10 (1.80) |
2.08 (2.01) |
-3.37% | Details |
| 10/21/2013 | JPMorgan | N/A | New Coverage | Overweight (N/A) |
7.00 (N/A) |
4.43 (2.01) |
-54.63% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
